Contact Us

marketing@medicilon.com

|

中

|

close search icon

中

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

01 One-stop Integrated Services

Drug Discovery Platform

Pharmaceutical Research Platform

Preclinical Research Services

Botanical Drug Preclinical R&D Technology Platform

02 Innovative Drug Services

ADC R&D Service Platform

PROTAC R&D Service Platform

mRNA Vaccine Bioanalysis Platform

Non-clinical Research for Cellular Immunotherapies

Nucleic Acid Drug R&D Platform

Peptide Drug Conjugate (PDC) R&D Service Platform

Antibody R&D Service

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection Platform

Metabolite Identification (MetID) Service Platform

Drug Forming Research Platform

Flow Cytometry Technology Platform

SEND Format Conversion Platform

Flow Sorting Platform

NanoString nCounter Detection Platform

Routes of Drug Administration Platform

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model Evaluation Platform

Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

05 Advanced Preparation R&D

Inhalation drug R&D platform

Ophthalmic drug R&D platform

Skin Topical Preparation R&D Platform

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

Talent Development

Talent Development

Talent Development

Medicilon Events

Featured Stories

2024-07-22Medicilon Events

The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together

On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.

2024-07-22Medicilon Events

5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"

Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.

Stock Information

Investment Contact

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

Intellectual Property Protection

Clients Testimonials

Medicilon Support

U.S.

Address: 470 Wildwood Ave, Woburn, MA 01801 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

ABOUT
Company Profile Management Team Honors and Awards Corporate Culture

SERVICES
Drug Discovery Pharmaceutical Research Preclinical Research

PLATFORM
One-stop Integrated Services Innovative Drug R&D Services Key Technical Services for Drug R&D Drug Efficacy Evaluation for Common Diseases High-end Preparations Technology Platform Targeted Drugs R&D Services Public Services Platform

CAREERS
Talent Development Recruitment

NEWS
Medicilon Events Featured Stories Market Events Videos A.C.E.

INVESTORS
Stock Information Investment Contact

CLIENT CENTER
Intellectual Property Protection Clients Testimonials Downloads Partnerships Medicilon Support Newsletters

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 |Website Map

关闭

中

Message

Contact Us

Business Inquiry

Global：

Email:marketing@medicilon.com

+1(626)986-9880(U.S.)

0044 7790 816 954 (Europe)

China：

Email: marketing@medicilon.com.cn

Tel: +86 (21) 5859-1500

Back To Top

Online Message×

Medicilon's Market Events

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

HomenewsMarket Events

Market Events

Hot information：

PBSS Workshop——Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings| PBSS Workshop——Translational PK/PD and Human Dose Projection for Antibodies/ADCs and Novel Therapeutic Modalities| EUROTOX 2024 - 58th Congress of the European Societies of Toxicology

Join Medicilon at BIO KOREA 2022: Beyond the Pandemic, into A Next Wave

BIO KOREA 2022 International Convention is only a couple weeks away! Medicilon is excited to exhibit at the conference.

Join Medicilon at BIO KOREA 2022: Beyond the Pandemic, into A Next Wave

Join Medicilon on Swiss Biotech Day 2022: A Truly Global Networking Day

Swiss Biotech Day 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference.

Join Medicilon on Swiss Biotech Day 2022: A Truly Global Networking Day

Join Medicilon at BioTrinity 2022: Catalysing Growth in the Life Sciences Industry

BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conference.

Join Medicilon at BioTrinity 2022: Catalysing Growth in the Life Sciences Industry

Join Medicilon at ELRIG Research & Innovation 2022 – for tomorrow's drug discovery

Medicilon welcomes you to join us at ELRIG RESEARCH & INNOVATION 2022.

Join Medicilon at ELRIG Research & Innovation 2022 – for tomorrow's drug discovery

Join Medicilon at AACR Annual Meeting 2022

Medicilon is excited to announce we will be exhibiting at AACR Annual Meeting 2022. Our US team Dr. Stephen Grant and Dr. Yang Wang will be hosting the booth at the conference (booth 3224).

Join Medicilon at AACR Annual Meeting 2022

Join Medicilon at 2022 SOT Annual Meeting

Medicilon is excited to exhibit at the 2022 SOT Annual Meeting. Our Vice President, Dr. Mingzhu Zhang, and Director of US BD, Yang Wang will be hosting the booth in the conference.

Join Medicilon at 2022 SOT Annual Meeting

Join Medicilon at Precision in Drug Discovery & Preclinical Summit

Medicilon is excited to exhibit at Precision in Drug Discovery & Preclinical (PDDP) Summit. The European PDDP summit series is coming to Frankfurt, Germany in September 27th-28th, 2022.

Join Medicilon at Precision in Drug Discovery & Preclinical Summit

Join Medicilon at ELRIG Drug Discovery 2021

Medicilon welcomes you to join us at Europe's largest meeting for life sciences industry professionals, ELRIG's annual Drug Discovery meeting.

Join Medicilon at ELRIG Drug Discovery 2021

Come and Join Medicilon at Discovery on Target (DOT) 2021

We are excited to announce that Medicilon will be attending the Discovery on Target (DOT) 2021. Our US Business Development team welcomes you to join us at the conference!

Come and Join Medicilon at Discovery on Target (DOT) 2021

Medicilon will participate ICTXV 2019

DATE: July 15-18, 2019

lOCATION: Hawaii

Medicilon will participate ICTXV 2019

Global

Address: 470 Wildwood Ave, Woburn, MA 01801 (America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->